Diversity of dopamine receptors: New molecular and pharmacological developments

Polish Journal of Pharmacology

Volumn 49, Issue 4, 1997, Pages 191-199

  Hartman, Deborah S ^a   Lanau, Fabienne ^a  

^a Preclinical Research   (Switzerland)

Author keywords

Attention deficit hyperactivity disorder; D1; D4.7; Genetic linkage; Knockout; Schizophrenia

Indexed keywords

2 PHENYL 4 [4 (2 PYRIMIDINYL) 1 PIPERAZINYLMETHYL]IMIDAZOLE; 2 PHENYL 4 [4 (2 PYRIMIDYL)PIPERAZINYL]METHYLIMIDAZOLE; 3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADRENALIN; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR; N [(1 ETHYL 2 PYRROLIDINYL)METHYL] 3 IODO 6 METHOXYSALICYLAMIDE; NORADRENALIN; RECEPTOR SUBTYPE; SONEPIPRAZOLE; UNCLASSIFIED DRUG;

ATTENTION DEFICIT DISORDER; BRAIN; DOPAMINERGIC SYSTEM; GENE EXPRESSION; GENETIC LINKAGE; HUMAN; NEUROTRANSMISSION; NONHUMAN; PERSONALITY; REVIEW; SCHIZOPHRENIA;

AMINO ACID SEQUENCE; ANIMALS; BRAIN; DNA, COMPLEMENTARY; DOPAMINE AGENTS; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NEUROTRANSMITTER AGENTS; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 0030828866     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. 4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Res., 1997, 752, 26-34.
2. 2 receptors. Nature, 1995, 377, 424-428.
3. 4 dopamine receptor gene and measures of Novelty Seeking. Nat. Genet., 1996, 12, 81-84.
4. 5 dopamine receptor: studies in primate brain and transfected mammalian cells. Proc. Nat. Acad. Sci. USA, 1995, 92, 3468-3472.
5. 2 dopamine receptor cDNA. Nature, 1988, 336, 783-787.
6. 4 receptor gene in psychotic patients. Biol. Psychiat., 1993, 34, 459-464.
7. 4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells. J. Biol. Chem., 1994, 269, 11813-11819.
8. Civelli O., Bunzow J. R., Grandy D. K.: Molecular diversity of the dopamine receptors. Annu. Rev. Pharmacol. Toxicol., 1993, 32, 281-307.
9. 4 receptors coupled to adenylate cyclase. Proc. Nat. Acad. Sci. USA, 1992, 89, 12093-12097.
10. 4 receptor in rat brain studied with sequence-specific antibodies. Mol. Brain Res., 1997, 45, 1-12.
11. 4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat. Genet., 1996, 12, 78-80.
12. 3 dopamine receptor generated by alternative splicing in the third cytoplasmic loop. J. Biol. Chem., 1993, 268, 5872-5878.
13. Fong T. M., Strader C. D.: Functional mapping of the ligand binding sites of G-protein coupled receptors. Med. Res. Rev., 1994, 14, 387-399.
14. Frey U., Huang Y.-Y., Kandel E. R.: Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science, 1993, 260, 1661-1664.
15. 1A knockout mice. Mol. Pharmacol., 1997, 51, 6-11.
16. 3 dopamine receptor produced through various patterns of alternative splicing. Biochem. Biophys. Res. Commun., 1991, 176, 1584-1592.
17. Hartman D. S., Civelli O.: Molecular attributes of dopamine receptors: new potential for antipsychotic drug development. Ann. Med., 1996, 28, 211-219.
18. Hartman D. S., Civelli O.: Dopamine receptor diversity: molecular and pharmacological perspectives. Prog. Drug Res., 1997, 48, 173-194.
19. 4 receptor regulation of retinomotor movement in isolated teleost cone inner-outer segments. J. Neurochem., 1995, 64, 1326-1335.
20. Hrabovsky E., Liposits Z.: Adrenergic innervation of dopamine neurons in the hypothalamic arcuate nucleus of the rat. Neurosci. Lett., 1994, 182, 143-146.
21. Kebabian J. W., Calne D. B.: Multiple receptors for dopamine. Nature, 1979, 277, 93-96.
22. 4 receptor. J. Med. Chem., 1996, 39, 1941-1942.
23. 4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol. Psychiat., 1996, 1, 121-124.
24. 4 receptor. J. Neurochem., 1997, 68, 804-812.
25. 1A-deficient mutant mice. J. Neurosci., 1996, 16, 5870-5882.
26. 4) gene. Hum. Mol. Genet., 1993, 2, 767-773.
27. 2 receptor. Eur. J. Pharmacol., 1992, 227, 205-214.
28. 4 receptor. Mol. Brain Res., 1995, 29, 157-162.
29. 4 dopamine receptor in a stable human cell line. FEBS Lett., 1994, 345, 147-150.
30. Meador-Woodruff J. H., Damask S. P., Wang J. C., Haroutunian V., Davis K. L., Watson S. J.: Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology, 1996, 15, 17-29.
31. Meador-Woodruff J. H., Grandy D. K., Van Tol H. H. M., Damask S. P., Little K. Y., Civelli O., Watson S. J.: Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology, 1994, 10, 239-248.
32. 4 receptor inhibits an L-type calcium current in cerebellar granule cells. Neuroscience, 1995, 68, 107-116.
33. 4 receptor selective antagonist. J. Pharmacol. Exp. Ther., 1996, 279, 1392-1403.
34. 1 deficient mice. Neuroreport, 1995, 6, 2314-2316.
35. 4 receptors in GABAergic neurons of the primate brain. Nature, 1996, 381, 245-248.
36. 4 dopamine receptors in postmortem striatum from patients with schizophrenia. J. Neurosci., 1995, 15, 2186-2191.
37. Nestler E.: Schizophrenia: an emerging pathophysiology. Nature, 1997, 382, 578-579.
38. 2 receptor affinity for drugs and inhibition of adenylyl cyclase. Mol. Pharmacol., 1991, 39, 733-739.
39. 4 receptors. Eur. J. Pharmacol., 1997, 319, 379-383.
40. 4 receptor gene: frequent occurrence of a null allele and observation of homozygosity. Hum. Mol. Genet., 1994, 3, 2207-2212.
41. Offermanns S., Simon M. I.: Galpha-15 and Galpha-16 couple a wide variety of receptors to phospholipase C. J. Biol. Chem., 1995, 270, 15175-15180.
42. 1 receptors in schizophrenia revealed by PET. Nature, 1997, 385, 634-636.
43. 4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system. New Biol., 1992, 4, 137-146.
44. 1b receptor. Eur. J. Pharmacol., 1994, 267, 85-93.
45. Routledge C., Marsden C. A.: Electrical stimulation of the C1 region of the ventrolateral medulla of the rat increases mean arterial pressure and adrenaline release in the posterior hypothalamus. Neuroscience, 1987, 20, 457-466.
46. 4 receptors. J. Med. Chem., 1996, 39, 1943-1945.
47. 4 receptors elevated in schizophrenia. Nature, 1993, 365, 441-445.
48. 3) as a target for neuroleptics. Nature, 1990, 347, 146-151.
49. 3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression. Brain Res., 1995, 681, 109-116.
50. 1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron, 1995, 14, 385-397.
51. Thurkauf A., Yuan J., Chen X., Wasley J. W., Meade R., Woodruff K.H., Huston K., Ross P.C.: 1-Phenyl-3-(aminomethyl)pyrroles as potential antipsychotic agents. Synthesis and dopamine receptor binding. J. Med. Chem., 1995, 38, 4950-4952.
52. Undie A. S., Friedman E.: Selective dopaminergic mechanism of dopamine and SKF38393 stimulation of inositol phosphate formation in rat brain. Eur. J. Pharmacol., 1992, 226, 297-302.
53. 1-like dopamine receptor that couples to activation of phosphoinositol metabolism in brain. J. Neurochem., 1994, 62, 2045-2048.
54. 4 receptor with high affinity for the antipsychotic clozapine. Nature, 1991, 350, 610-614.
55. 4 receptor variants in the human population. Nature, 1992, 358, 149-152.
56. 2 receptor binding. Science, 1996, 273, 1225-1227.
57. 2 dopamine receptor using site-directed mutagenesis. J. Neurochem., 1996, 66, 394-402.
58. 1 receptor mutant mice. Cell, 1994, 79, 945-955.
59. 1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell, 1994, 79, 729-742.
60. 4-like dopamine receptor. J. Neural Transm. - Gen. Sect., 1994, 97, 107-117.
61. 4-like subtype: pharmacological characterization. Neurochem. Int., 1994, 24, 275-280.